Krzysztof Tomasiewicz Selected Research

Krzysztof Tomasiewicz Research Topics

Disease

20	Infections 04/2024 - 04/2004
11	Chronic Hepatitis C 01/2022 - 01/2005
10	Fibrosis (Cirrhosis) 03/2023 - 06/2017
7	COVID-19 09/2022 - 12/2020
5	Liver Cirrhosis (Hepatic Cirrhosis) 07/2020 - 09/2016
3	Non-alcoholic Fatty Liver Disease 05/2023 - 09/2018
3	Renal Insufficiency (Renal Failure) 03/2023 - 06/2017
3	Coinfection 01/2022 - 06/2017
3	Hepatitis C 01/2022 - 01/2005
3	Hepatocellular Carcinoma (Hepatoma) 07/2021 - 06/2017
3	Liver Diseases (Liver Disease) 05/2021 - 09/2017
2	HIV Infections (HIV Infection) 01/2022 - 05/2021
2	Communicable Diseases (Infectious Diseases) 09/2018 - 01/2004
2	Rabies (Hydrophobia) 01/2018 - 01/2006
2	Lyme Disease (Disease, Lyme) 01/2016 - 01/2012
1	Liver Failure 03/2023
1	Neoplasms (Cancer) 09/2022
1	Chronic Hepatitis B 09/2021
1	End Stage Liver Disease 05/2021
1	Sleepiness 01/2021
1	Hepatic Encephalopathy 01/2021
1	Proteinuria 01/2021
1	Alcoholic Fatty Liver 09/2018
1	Kidney Diseases (Kidney Disease) 06/2017
1	Persistent Infection 06/2017
1	Autoimmune Diseases (Autoimmune Disease) 06/2015
1	Aspiration Pneumonia 01/2013
1	Wounds and Injuries (Trauma) 01/2013
1	Fat Embolism 01/2013
1	Burns 01/2013
1	Trichophyton infection 10/2012
1	Borrelia Infections 01/2012
1	Vitiligo 01/2006

Drug/Important Bio-Agent (IBA)

17	Antiviral Agents (Antivirals)IBA 04/2024 - 02/2016
8	InterferonsIBA 05/2021 - 01/2006
7	Ribavirin (Virazole)FDA LinkGeneric 07/2021 - 01/2005
3	Proteins (Proteins, Gene)FDA Link 05/2023 - 01/2012
3	remdesivirIBA 09/2022 - 12/2020
3	Ritonavir (Norvir)FDA Link 07/2021 - 09/2019
3	paritaprevirIBA 07/2021 - 09/2019
3	ombitasvirIBA 07/2021 - 09/2019
3	dasabuvirIBA 07/2021 - 09/2019
2	Oxygen (Dioxygen)IBA 04/2021 - 01/2021
2	tocilizumab (atlizumab)FDA Link 04/2021 - 01/2021
2	glecaprevir and pibrentasvirIBA 01/2019 - 01/2019
2	Immunoglobulins (Immunoglobulin)IBA 01/2018 - 01/2006
2	Interferon-alpha (Interferon Alfa)IBA 02/2016 - 01/2009
2	DNA (Deoxyribonucleic Acid)IBA 11/2015 - 01/2004
1	sofosbuvir drug combination ledipasvirIBA 01/2022
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 01/2022
1	molnupiravirIBA 01/2022
1	nirmatrelvir and ritonavir drug combinationIBA 01/2022
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2022
1	LDL Lipoproteins (beta Lipoproteins)IBA 09/2021
1	HDL LipoproteinsIBA 09/2021
1	Triglycerides (Triacylglycerol)IBA 09/2021
1	Tenofovir (Viread)FDA Link 09/2021
1	CholesterolIBA 09/2021
1	AmberIBA 07/2021
1	CytokinesIBA 04/2021
1	Interleukin-6 (Interleukin 6)IBA 04/2021
1	Pregnanolone (Allopregnanolone)IBA 01/2021
1	GABA-A Receptors (GABA(A) Receptor)IBA 01/2021
1	milk-derived factorIBA 01/2021
1	golexanoloneIBA 01/2021
1	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 01/2021
1	CreatinineIBA 01/2021
1	Calcineurin InhibitorsIBA 01/2021
1	SteroidsIBA 01/2021
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 10/2020
1	elbasvirIBA 07/2020
1	grazoprevirIBA 07/2020
1	ruzasvirIBA 01/2019
1	NucleotidesIBA 01/2019
1	uprifosbuvirIBA 01/2019
1	SofosbuvirIBA 01/2019
1	Prostaglandins EIBA 09/2018
1	ledipasvirIBA 09/2017
1	ElementsIBA 09/2016
1	Immunologic Factors (Immunomodulators)IBA 01/2016
1	Hepatitis B e AntigensIBA 11/2015
1	isoconazoleIBA 10/2012
1	ValeratesIBA 10/2012
1	AntibodiesIBA 01/2012
1	Complement Factor H (Factor H)IBA 01/2012
1	Anti-Idiotypic AntibodiesIBA 01/2012

Therapy/Procedure

21	Therapeutics 03/2023 - 01/2006
2	Aftercare (After-Treatment) 07/2021 - 01/2021
2	Duration of Therapy 03/2020 - 06/2017
1	Kidney Transplantation 01/2021
1	Activities of Daily Living (ADL) 01/2021
1	Renal Dialysis (Hemodialysis) 01/2021
1	Polypharmacy 09/2019
1	Opiate Substitution Treatment 01/2019
1	Retreatment 06/2017
1	Organ Transplantation 06/2017
1	Liver Transplantation 06/2017
1	Immunotherapy 06/2015
1	Blood Transfusion (Blood Transfusions) 01/2013
1	Cryotherapy (Therapy, Cold) 10/2012